Hikma Pharmaceutical | 销售和管理费用



Selling And Administration Expenses 更改 日
Almirall EUR 91.3M 55.52M 2025-03
argenx SE USD 321.35M 45.11M 2025-06
AstraZeneca USD 5.01B 1.42B 2025-06
Autolus Therapeutics Ltd 27.96M 1.58M 2025-06
Bayer EUR 3.55B 162M 2025-06
Fresenius EUR 740M 97M 2025-06
Galapagos EUR 30.67M 13.12M 2025-06
Genmab DKK 144M 18M 2025-06
GlaxoSmithKline GBP 2.14B 80M 2025-06
GRIFOLS EUR 282.76M 41.9M 2025-06
Hikma Pharmaceutical USD 288M 8M 2024-12
Merck EUR 1.48B 9M 2025-06
Orion EUR 96.7M 12.4M 2025-06
Recordati EUR 186.98M 5.59M 2025-06
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.63B 408M 2025-06
UCB EUR 1.29B 221M 2024-12


Hikma Pharmaceutical 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Aug 2025.